FdaApplication

NDA 212904

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAVEO PHARMACEUTICALS INC
application_typeNDA
approval_date2021-03-10

Products (2)

ProductActive ingredientStrengthDosage form
FOTIVDATIVOZANIB HYDROCHLORIDEEQ 1.34MG BASECAPSULE;ORAL
FOTIVDATIVOZANIB HYDROCHLORIDEEQ 0.89MG BASECAPSULE;ORAL

2 products